Committee
Consult the new user guides
For assistance, please contact us
Consult the new user guides
For assistance, please contact us
Add search criteria
Results: 1 - 100 of 1469
View Sean Casey Profile
Lib. (PE)
Thank you, Chair.
Ms. Vaillancourt, on July 17, 2022, you published a news release in which you indicated that the union obtained confidential surveys carried out by the Department of Veterans Affairs. Do you recall that?
View Sean Casey Profile
Lib. (PE)
On that confidential survey, did you find that it contained accurate and comprehensive information?
View Sean Casey Profile
Lib. (PE)
Ms. Vaillancourt issued a press release on July 17, 2022, citing a confidential survey carried out by the department. My question is whether you found that survey to contain valuable and accurate information.
View Sean Casey Profile
Lib. (PE)
You would agree, then, that most of the employees were well informed about the PCVRS service contract?
View Sean Casey Profile
Lib. (PE)
Survey results: page 6, question 2. “I am well informed of changes that will take place with the implementation of the new Partners in Canadian Veterans Rehabilitation Services contract.”
Sixty-eight per cent agree or slightly agree. Is that information incorrect and unreliable?
View Sean Casey Profile
Lib. (PE)
Do you agree that most who responded to the survey reported that they understood the reasons for the upcoming changes?
View Sean Casey Profile
Lib. (PE)
Have you changed your mind since we started this conversation with respect to the accuracy, reliability and value of this confidential survey?
View Sean Casey Profile
Lib. (PE)
Have you changed your mind since we started this conversation?
The Chair: Through the chair....
Mr. Sean Casey: Okay, okay.
View Sean Casey Profile
Lib. (PE)
Mr. Chair, I wish to ask the witness whether he has changed his mind, since we started this conversation, with respect to the accuracy, the completeness and the reliability of the confidential survey that was the subject of their press release in July 2022.
View Sean Casey Profile
Lib. (PE)
Okay. If it's still your view that this information is accurate and reliable and forms the basis for your public remarks in July, then you would agree with me that most people understood the impact of the proposed changes.
View Sean Casey Profile
Lib. (PE)
Is that what you're saying?
View Sean Casey Profile
Lib. (PE)
Okay.
Ms. Vaillancourt, are case managers overworked?
View Sean Casey Profile
Lib. (PE)
Their caseloads are too high?
View Sean Casey Profile
Lib. (PE)
Therefore, would it be a good idea to get them some support in their work?
View Sean Casey Profile
Lib. (PE)
So it would be support from people who pay union dues.
View Sean Casey Profile
Lib. (PE)
Thank you very much, Mr. Chair.
Ms. Vaillancourt, I'm going to read something to you. Tell me if you recognize this.
I continue to meet with Senior Management on various topics and concerns while working to build the collaboration and consultation between the Department and the Union at all levels.
Do you recognize that?
View Sean Casey Profile
Lib. (PE)
You wrote those words in your report to the members in September of this year, about a month before you called for the minister's resignation.
Could you outline for the committee the steps that you took between May and August to build collaboration and consultation between the department and the union at all levels?
View Sean Casey Profile
Lib. (PE)
You would agree that contracting—
View Sean Casey Profile
Lib. (PE)
Mr. Chair, I'd like the witness to advise whether this idea of contracting out rehabilitation services is something new or is something that the department has been doing since 2006.
View Sean Casey Profile
Lib. (PE)
With respect to what you reported to your members, I asked you about what steps you had taken to build collaboration, and you responded with what the department hasn't done. Can you take another try and tell me what you have done as per your report to your members?
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
Lib. (PE)
Thank you very much, Mr. Chair.
In your responses to questions from Mr. Julian and Mr. Brassard, it appears that you now have some concerns over the sample size of the confidential survey. Has the union done a survey of its own that's more comprehensive?
View Sean Casey Profile
Lib. (PE)
Then is your account today based on anecdotal conversations and the confidential survey?
View Sean Casey Profile
Lib. (PE)
What would you call them, if you don't have a scientific survey?
View Sean Casey Profile
Lib. (PE)
Your preoccupation, expressed in your responses to questions from Mr. Brassard and Mr. Julian, didn't really enter into your thinking when you referred to and relied upon those surveys in your press release of July, 2022. Is that correct?
View Sean Casey Profile
Lib. (PE)
You thought enough of the department's confidential survey to issue a public statement about it in July. Is that right?
View Sean Casey Profile
Lib. (PE)
Yes. Okay.
You've mounted a public awareness campaign around this contract. Have you approached the Legion to see if they would join with you on concerns and critique of the contract?
View Sean Casey Profile
Lib. (PE)
What did the Legion do?
View Sean Casey Profile
Lib. (PE)
I call this meeting to order.
Welcome to meeting number 42 of the House of Commons Standing Committee on Health.
Today we meet for two hours with witnesses on our study of over-the-counter pediatric medication.
I see that we have a couple of members participating online who are well aware of the procedures and the fact that the hybrid format is permitted pursuant to the House order of June 23, 2022.
We're going to get right into welcoming the witnesses. We have a panel in front of us today who are quite familiar with the committee, as we are with them.
We have Dr. Stephen Lucas, deputy minister of Health Canada; Dr. Supriya Sharma, chief medical advisor and senior medical advisor in the health products and food branch; Stefania Trombetti, assistant deputy minister, regulatory operations and enforcement branch; Linsey Hollett, director general, health product compliance; and Dr. Kim Godard, director, health product inspection and licensing division, regulatory operations and enforcement branch.
Thank you all for being with us here today.
I understand that Dr. Lucas is going to lead us off.
You have up to five minutes, Doctor. Welcome to the committee. Thanks for being here. You have the floor.
View Sean Casey Profile
Lib. (PE)
Thank you, Dr. Lucas.
We're now going to begin with rounds of questions, starting with Mrs. Goodridge, please, for six minutes.
View Sean Casey Profile
Lib. (PE)
We're well past time. Keep your response short, please.
View Sean Casey Profile
Lib. (PE)
Thank you.
Next up is Dr. Powlowski for six minutes.
View Sean Casey Profile
Lib. (PE)
Thank you, Dr. Sharma.
Mr. Garon, you have the floor for six minutes.
View Sean Casey Profile
Lib. (PE)
Thank you, Dr. Sharma.
Go ahead, Mr. Davies, please, for six minutes.
View Sean Casey Profile
Lib. (PE)
Thank you, Dr. Lucas.
Next up we have Dr. Ellis, please, for five minutes.
View Sean Casey Profile
Lib. (PE)
Dr. Sharma, we are well past time, so please be concise. If you prefer to augment your answer in writing, that would be fine, as well.
Go ahead.
View Sean Casey Profile
Lib. (PE)
Thank you, Dr. Sharma.
Next we have Ms. Sidhu, please, for five minutes.
View Sean Casey Profile
Lib. (PE)
Thank you, Ms. Hollett.
Mr. Garon, you have the floor for two and a half minutes.
View Sean Casey Profile
Lib. (PE)
Thank you, Mr. Lucas.
Mr. Davies, you have two and a half minutes.
View Sean Casey Profile
Lib. (PE)
You get the last word, Dr. Lucas. That was the last question.
Go ahead.
View Sean Casey Profile
Lib. (PE)
Dr. Lucas and your team, thank you so much for being here. We have another panel of witnesses who will be speaking to this issue in the second half of the meeting. As always, we appreciate your coming, in this instance on fairly short notice, and the patience you've exhibited with us on this very difficult issue. Thanks again.
Colleagues, we will suspend for five minutes while we bring in the next panel of witnesses. You can stretch your legs and get a bite if you want.
We stand suspended.
View Sean Casey Profile
Lib. (PE)
I call the meeting back to order.
I'd like to welcome our witnesses for the second panel.
I have just a few comments for the benefit of the new witnesses, specifically Dr. Ahmed, who is participating online.
Dr. Ahmed, you have interpretation on your screen. You have the choice of either floor, English or French.
For those in the room, you can use the earpiece to select the desired channel.
Mr. Garon, I can confirm that sound and connection tests have been carried out with Dr. Ahmed and that the sound quality is good.
I would now like to welcome our next panel of witnesses.
From the Association québécoise des distributeurs en pharmacie, we have Mr. Hugues Mousseau, director general.
From Children's Healthcare Canada, we have Emily Gruenwoldt, president and chief executive officer.
From the Critical Drugs Coalition, we have Dr. Saad Ahmed, physician, appearing by video conference from Vancouver.
Finally, from Food, Health & Consumer Products of Canada, we have Gerry Harrington, senior adviser.
Thanks to all.
Mr. Mousseau, I invite you to begin. You have five minutes for your opening statement. Welcome to the committee, sir.
You have the floor.
View Sean Casey Profile
Lib. (PE)
Thank you, Mr. Mousseau.
Next we have Emily Gruenwoldt, president and CEO of Children's Healthcare Canada.
Welcome back to the committee, Ms. Gruenwoldt. You have five minutes.
View Sean Casey Profile
Lib. (PE)
Thank you very much, Ms. Gruenwoldt.
Next, from the Critical Drugs Coalition, we have Dr. Saad Ahmed, physician.
Dr. Ahmed, welcome to the committee. You have the floor.
View Sean Casey Profile
Lib. (PE)
Thank you, Dr. Ahmed.
Finally, we have Gerry Harrington, senior adviser with Food, Health & Consumer Products of Canada. Welcome to the committee, Mr. Harrington. You have the floor.
View Sean Casey Profile
Lib. (PE)
Thank you, Mr. Harrington.
We're going to begin the rounds of questions now, starting with Mr. Jeneroux for six minutes.
View Sean Casey Profile
Lib. (PE)
Thank you, Dr. Ellis.
The motion is in order, so the debate is now on the motion. The floor is open.
Go ahead, Mr. van Koeverden.
View Sean Casey Profile
Lib. (PE)
Dr. Ellis is next, please.
View Sean Casey Profile
Lib. (PE)
Mr. Doherty is next.
Mr. Doherty, we can't hear you. It's been suggested that your microphone is muted at the source. Do you want to try it there now?
We can hear you now. You have the floor.
View Sean Casey Profile
Lib. (PE)
Go ahead, Dr. Powlowski.
View Sean Casey Profile
Lib. (PE)
Go ahead, Mr. van Koeverden.
View Sean Casey Profile
Lib. (PE)
A motion to adjourn debate is not debatable. All those in favour of adjourning debate on the motion, please raise your right hand.
Debate on the motion is adjourned. We are going to return to rounds of questions.
Next up is Mr. Jowhari for six minutes.
View Sean Casey Profile
Lib. (PE)
Thank you, Mr. Jowhari.
Mr. Garon, you have the floor for six minutes.
View Sean Casey Profile
Lib. (PE)
Thank you, Mr. Mousseau.
Next is Mr. Davies, please, for six minutes.
View Sean Casey Profile
Lib. (PE)
You have 40 seconds, Mr. van Koeverden.
View Sean Casey Profile
Lib. (PE)
You actually have a minute and 40 seconds.
View Sean Casey Profile
Lib. (PE)
Answer very quickly. We're out of time.
View Sean Casey Profile
Lib. (PE)
Thank you, Mr. van Koeverden.
Thank you, Ms. Gruenwoldt.
Colleagues, we have a couple of minutes left. We're going back to the Conservatives.
Dr. Ellis, knowing we have only a couple of minutes, go ahead.
View Sean Casey Profile
Lib. (PE)
It's a non-debatable motion that we resume debate on the motion in the minute and a half that we have left.
(Motion agreed to)
The Chair: The debate is on the motion for the next minute.
We'll have Dr. Ellis, Mr. Davies—
View Sean Casey Profile
Lib. (PE)
—and Mr. van Koeverden.
Go ahead, Dr. Ellis.
View Sean Casey Profile
Lib. (PE)
We can't do that until the speakers list is exhausted.
Go ahead, Mr. Davies.
View Sean Casey Profile
Lib. (PE)
To both the witnesses, thank you so much for being with us. There was a lot of information packed into an hour. We're very grateful for your time and respectful of it, which is why we thank you.
You're welcome to stay, but you're free to leave. Thank you so much.
Go ahead, Mr. van Koeverden.
View Sean Casey Profile
Lib. (PE)
Is there any further debate on the motion?
Go ahead, Dr. Powlowski.
View Sean Casey Profile
Lib. (PE)
Go ahead, Mr. van Koeverden.
View Sean Casey Profile
Lib. (PE)
The motion to adjourn is not debatable.
All those in favour of adjourning the meeting?
(Motion agreed to)
The Chair: The motion is carried.
The meeting is adjourned.
View Sean Casey Profile
Lib. (PE)
I call this meeting to order. Welcome to meeting number 39 of the House of Commons Standing Committee on Health.
Today we meet for clause-by-clause consideration of Bill C‑31, an act respecting cost of living relief measures related to dental care and rental housing.
View Sean Casey Profile
Lib. (PE)
Yes. They're here. Philippe Méla and Marie-Hélène Sauvé are legislative clerks who are here to help us. It is permissible to bring forward an amendment for which there has not been given notice, but once we get to 12 o'clock, we will be going straight to a vote on those, and only those, for which notice has been given.
If there is an amendment proposed for which there was no notice given, which is what you're contemplating, you are welcome to do that. It will have to be done in writing, in both official languages, and it will have to be dispensed with before midnight or it effectively falls off the table.
View Sean Casey Profile
Lib. (PE)
It will be able to be voted on provided that vote happens before midnight.
View Sean Casey Profile
Lib. (PE)
Ms. Sauvé has some additional information, Mr. Doherty.
Go ahead.
View Sean Casey Profile
Lib. (PE)
Today's meeting is taking place in a hybrid format, pursuant to the House order of June 23, 2022.
I would now like to welcome the officials who are with us this evening. We are well supported with plenty of expertise around the table.
We have, from the Canada Mortgage and Housing Corporation, Ms. Nadine Leblanc, senior vice-president, policy; Ms. Patricia Roset-Zuppa, vice-president, policy development; and Ms. Louise Michel, director, legal services. From the assessment, benefit and service branch of the Canada Revenue Agency, we have Ms. Gillian Pranke, assistant commissioner; and Ms. Heather Daniels, director general, benefit programs directorate. From Health Canada, we have Ms. Lynne Tomson, associate assistant deputy minister, strategic policy branch.
As you just heard, we also have with us the legislative clerks, Marie-Hélène Sauvé and Philippe Méla.
The good folks at the back of the room should be able to handle any technical questions you have with respect to the substance of the bill or the amendments. The good folks at the front of the room will be able to handle your legal and technical questions on that end.
There will be no opening statements. Everyone you see here is here as a resource to help us do our work.
We're now going to move to clause-by-clause consideration of Bill C-31, but I have a bit of a script here for you.
As the name indicates, this is an examination of all the clauses in the order in which they appear in the bill. I will call each clause successively, and until midnight tonight, each clause is subject to debate and a vote. If there is an amendment to the clause in question, I will recognize the member proposing it, who may explain it. The amendment will then be open for debate. When no further members wish to intervene, the amendment will be voted on. Amendments will be considered in the order in which they appear in the bill and in the package each member received from the clerk.
Members should note that amendments must be submitted in writing to the clerk of the committee.
The chair will go slowly to allow all members to follow the proceedings properly. Amendments have been given an alphanumeric number in the top right corner to indicate which party submitted them. There's no need for a seconder to move an amendment. Once it is moved, you will need unanimous consent to withdraw it.
During debate on an amendment, members are permitted to move subamendments. These subamendments must be submitted in writing. They do not require the approval of the mover of the amendment. Only one subamendment may be considered at a time, and that subamendment cannot be amended. When a subamendment is moved, it is voted on first. Then another subamendment may be moved, or the committee may consider the main amendment and vote on it.
Once every clause has been voted on, the committee will vote on the short title, the title, and the bill itself. An order to reprint the bill may be required if amendments are adopted so that the House has a proper copy for use at report stage.
Finally, the committee will have to order the chair to report the bill to the House. That report contains only the text of any adopted amendments, as well as an indication of any deleted clauses.
We're now proceeding with clause-by-clause consideration.
Pursuant to Standing Order 75(1), consideration of clause 1, the short title, is postponed. I therefore call clause 2.
(On clause 2)
The Chair: I understand there is an amendment proposed to clause 2.
Monsieur Garon, do you wish to introduce the amendment?
View Sean Casey Profile
Lib. (PE)
Mr. Garon, go ahead.
View Sean Casey Profile
Lib. (PE)
Thank you, Mr. Garon.
Next is Ms. Sidhu, and then Mr. Davies.
View Sean Casey Profile
Lib. (PE)
Thank you, Ms. Sidhu.
Mr. Davies is next, and then Mrs. Goodridge.
View Sean Casey Profile
Lib. (PE)
Thank you, Mr. Davies.
We'll have Mrs. Goodridge, please.
View Sean Casey Profile
Lib. (PE)
Ms. Sauvé, do you want to help us with that?
View Sean Casey Profile
Lib. (PE)
Next is Monsieur Garon.
View Sean Casey Profile
Lib. (PE)
We'll have Mr. Doherty, and then Mr. van Koeverden, please.
View Sean Casey Profile
Lib. (PE)
Mr. van Koeverden, go ahead.
View Sean Casey Profile
Lib. (PE)
Dr. Ellis, you have the floor.
View Sean Casey Profile
Lib. (PE)
We'll have Mrs. Goodridge, please.
View Sean Casey Profile
Lib. (PE)
Just before you answer, I'd like to provide some guidance here.
We are now debating an amendment to clause 2. The question that you're being asked to answer is in connection to clause 7. In fairness, we've gone a bit away from where we should be. She has asked the question and I would ask you to answer it, but I raise that as a note of caution for everyone here. We will get to clause 7.
Go ahead.
View Sean Casey Profile
Lib. (PE)
Actually, Mrs. Goodridge, it's my bad.
You said it was clause 7. It was actually subclause 7 within clause 2. You're entirely within your rights and I shouldn't have provided the guidance or intervened or interrupted or anything of the sort. You are absolutely on point and you should go right ahead.
View Sean Casey Profile
Lib. (PE)
Mr. Shields, go ahead, please.
View Sean Casey Profile
Lib. (PE)
Thank you.
Would you like to respond to that comment, Mr. Garon?
View Sean Casey Profile
Lib. (PE)
Mr. Davies, go ahead.
View Sean Casey Profile
Lib. (PE)
Mr. Doherty, go ahead.
View Sean Casey Profile
Lib. (PE)
Mr. van Koeverden, go ahead.
View Sean Casey Profile
Lib. (PE)
Mr. van Koeverden, go ahead.
View Sean Casey Profile
Lib. (PE)
Dr. Ellis, go ahead, please.
View Sean Casey Profile
Lib. (PE)
You have the floor, Mr. Garon.
View Sean Casey Profile
Lib. (PE)
No, it hasn't yet been adopted. According to the established rules, we will do that at the end. We started with clause 2, but we'll come back to clause 1 later.
View Sean Casey Profile
Lib. (PE)
That concludes the speakers list for now.
Is there any further debate on BQ-1?
Seeing none, are we ready for the question?
(Amendment negatived [See Minutes of Proceedings])
View Sean Casey Profile
Lib. (PE)
The amendment is defeated.
The debate now is on clause 2, unamended. Is there any discussion on clause 2?
Oh, I'm sorry. There's another amendment.
Mr. Garon, you filed a second amendment. Would you like to move it now?
View Sean Casey Profile
Lib. (PE)
Thank you, Mr. Garon.
Part 1 of Bill C‑31 enacts the dental benefit act, which provides for the establishment of an application-based interim dental benefit for eligible Canadian children under 12 years old across all provinces and territories. The amendment proposes to add a new clause, clause 2.1, which allows provinces to opt out of the dental benefit program and to receive financial compensation for opting out.
House of Commons Procedure and Practice, third edition, states on page 770:
An amendment to a bill that was referred to a committee after second reading is out of order if it is beyond the scope and principle of the bill.
The document further states on page 772:
Since an amendment may not infringe upon the financial initiative of the Crown, it is inadmissible if it imposes a charge on the public treasury, or if it extends the objects or purposes or relaxes the conditions and qualifications specified in the royal recommendation.
In the opinion of the chair, the amendment is contrary to the bill's stated principle of creating a national dental benefit program, since there is no mechanism to allow any province or territory to opt out of the program. In addition, the amendment proposes to alter the terms and conditions for spending provided in the royal recommendation.
Therefore, I rule the amendment inadmissible.
View Sean Casey Profile
Lib. (PE)
One moment, Mr. Garon.
Mr. Davies, I agree with you.
Mr. Garon, you really only have one option at this point. You can't debate the decision I just made, but you can challenge it if you wish. The committee will therefore decide if the chair's decision should be upheld.
Mr. Davies made a very good point: A decision by the chair cannot be debated. Your only option is to challenge my decision.
View Sean Casey Profile
Lib. (PE)
The ruling of the chair has been challenged and a vote has been requested. That's a non-debatable motion.
Therefore, the question for the committee is, shall the ruling of the chair stand?
(Ruling of the chair sustained)
The Chair: The ruling of the chair is upheld. Therefore, we are now ready to debate clause 2, unamended.
Go ahead, Mr. Davies.
View Sean Casey Profile
Lib. (PE)
Okay.
Do you now have interpretation?
View Sean Casey Profile
Lib. (PE)
Okay.
Mr. Davies has posed a question as to the fact that the territories are not included in paragraph 4(1)(d). I would like to refer the question to the legislative clerks or the officials.
Who wants to take that?
Go ahead, Ms. Tomson.
View Sean Casey Profile
Lib. (PE)
Are there further interventions with respect to clause 2?
Go ahead, Mr. Shields.
Results: 1 - 100 of 1469 | Page: 1 of 15

1
2
3
4
5
6
7
8
9
10
>
>|
Export As: XML CSV RSS

For more data options, please see Open Data